Omada Health CFO sells 1,884 shares under plan

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an open-market sale of 1,884 shares of common stock at $13.94 per share on March 13, 2026.

Rhea-AI Filing Summary

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an open-market sale of 1,884 shares of common stock at $13.94 per share on March 13, 2026. The transaction was made under a Rule 10b5-1 trading plan adopted on August 15, 2025.

After this sale, Cook directly holds 200,512 shares of Omada Health common stock. The sale represents a relatively small portion of his reported holdings and reflects a pre-planned trading arrangement rather than a discretionary trade.

Insider Trade Summary 10b5-1

Net Seller: 1,884 shares

Net Sell 1 txn

Insider Cook Steven L.

Role Chief Financial Officer

Sold 1,884 shs ($26K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,884	$13.94	$26K

Holdings After Transaction: Common Stock — 200,512 shares (Direct)

Footnotes (1)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) report for its CFO?

Omada Health reported that CFO Steven L. Cook sold 1,884 shares of common stock. The sale occurred on March 13, 2026 at $13.94 per share in an open-market transaction executed under a pre-established Rule 10b5-1 trading plan.

How many Omada Health (OMDA) shares did the CFO sell and at what price?

CFO Steven L. Cook sold 1,884 shares of Omada Health common stock at $13.94 per share. This open-market sale was disclosed in a Form 4 filing and was executed pursuant to a Rule 10b5-1 trading plan adopted in August 2025.

How many Omada Health (OMDA) shares does the CFO still own after this sale?

Following the reported sale, CFO Steven L. Cook holds 200,512 shares of Omada Health common stock directly. This remaining position indicates that the 1,884-share transaction represents a small fraction of his overall reported holdings in the company.

Was the Omada Health (OMDA) CFO’s stock sale done under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Steven L. Cook on August 15, 2025. Such plans pre-schedule trades, reducing the significance of transaction timing as an indicator of insider sentiment.

What type of transaction did Omada Health (OMDA) disclose for its CFO on March 13, 2026?

The company disclosed an open-market sale of common stock by CFO Steven L. Cook. He sold 1,884 shares at $13.94 per share, classified as a sale in the open market or a private transaction, with ownership reported as direct.

Does the Omada Health (OMDA) Form 4 show any option exercises by the CFO?

No option exercises are shown in this Form 4. The transactionSummary reports zero derivative exercises and zero derivative transactions, indicating the only reported activity is the 1,884-share open-market sale of common stock by the CFO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		S(1)		1,884	D	$13.94	200,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2025.

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.